意大利中部人口中可修改的心血管风险因素的负担:试点研究
Emma Altobelli1, Francesca Marzi1, Paolo Matteo Angeletti1
1Department of Life, Public Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Healthcare (Basel, Switzerland)
|May 27, 2023
概括
这项试点研究选了45-59岁的患者,以检测心血管疾病的危险因素. 虽然血压和脂质是有利的,但发现了高吸烟率和久坐不动的生活方式,突出了公共卫生干预的领域.
科学领域:
- 公共卫生 公共卫生
- 心血管疾病研究研究
- 预防医学 预防医学
背景情况:
- 20世纪中叶,心血管疾病 (CVD) 成为一个主要的健康问题.
- 识别可修改的风险因素 (RF) 对于预防心血管疾病至关重要.
- 试点研究对于评估查策略至关重要.
研究的目的:
- 为45-59岁的公民试行一个查计划.
- 在这个人口群体中识别可修改的心血管疾病风险因素.
- 评估基于人口的查计划的实用性和感知.
主要方法:
- 从2019年2月到2020年2月,在意大利中部进行了一项试点查研究.
- 在45-59岁的参与者中,评估了脂质状况,血糖,人体参数和生活方式.
- 评估了选过程的感知效用和组织.
主要成果:
- 与国家数据相比,参与者表现出更好的血压和脂质概况.
- 确定的重大风险因素包括高吸烟率 (57%),久坐的生活方式 (24.5%) 和腰围升高.
- 大多数参与者对查组织的评价是积极的.
结论:
- 该研究提供了45-59岁公民在疫情前的健康快照.
- 确定的风险因素,如吸烟和久坐不动,需要有针对性的公共卫生干预措施.
- 人口认为心血管查很重要,支持未来的公共卫生倡议.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Coronary Artery Disease I: Introduction
34
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34
Factors affecting Blood pressure
3.4K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.4K
Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Hypertension IV: Drug Therapy and Lifestyle Modifications
20
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
20
Coronary Artery Disease II: Pathophysiology
16
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16


